NIH: Continuation of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Coordination and Data Management Center (CPDPC-CDMC) (U01 Clinical Trial Optional)RFA-DK-19-504
Sponsor: NIHInternal Deadline: 10/29/2019Institutional Submission Limit: 1Sponsor Deadline: 12/17/2019Program Website
NIH: Continuation of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer Coordination and Data Management Center (CPDPC-CDMC) (U01 Clinical Trial Optional)RFA-DK-19-504This funding opportunity announcement (FOA) is a limited invitation for U01 application for one Coordination and Data Management Center (CDMC) to continue the consortium to study Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC) to conduct and complete ongoing studies on chronic pancreatitis (CP) and factors that increase the risk of pancreatic cancer in patients (children and adults) with CP, pancreatogenic (type 3c) diabetes (T3cDM) and in patients with newly diagnosed diabetes. The CPDPC is composed of several Clinical Centers (CC) and one Coordination and Data Management Center (CDMC)
USC may only submit only one application in response to this program announcement. Your application submission MUST be coordinated with the Office of the Vice President for Research. Please send a two page abstract via email to Richard White (whitejrw@mailbox.sc.edu) by October 29, 2019. In addition to the 2-page abstract, you should also submit a biosketch for the PI.
NIH indicates that a letter of intent is NOT REQUIRED and a completed application is due by December 17, 2019. For more information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-19-504.html